Skin Cancer

SKIN CANCER

FEATURE ARTICLE

Melanoma Risk and Biologic Therapy: Is There a Link?

Because the TNF-α pathway plays a critical role in tumor surveillance, there is concern that inhibition of this pathway could predispose patients to certain malignancies.

LATEST NEWS

This PD-1 inhibitor is effective for treating melanoma, though it can be highly toxic and there is a

Benefit of Adjuvant Dabrafenib Plus Trametinib Persists in Melanoma

For patients with stage III melanoma with BRAF V600E or V600K mutations, 12 months of adjuvant dabrafenib plus trametinib results in increased survival without relapse or distant metastasis at 5 years.

Predicting Melanoma in Small- and Medium-Sized Congenital Nevi

Colby Stong

Predictors of dermatoscopic melanoma were investigated in a study that revealed a novel finding.

Permanent Hair Dye Not Linked to Cancer Risk, Mortality

Use of permanent hair dye is not associated with the risk for most cancers or cancer mortality.

Investigators estimated the effects of immunosuppression on poor outcomes in multiple cutaneous squamous cell carcinoma.

Prior History of SCC Could Be a Red Flag for Development of SCC in the Setting of CLL

Susan Moench, PhD, PA-C

In this study, a cohort of patients with newly diagnosed CLL was followed to identify the incidence of SCC skin cancer and its associated risk factors in this population.

Follow-up Calls After Mohs Surgery Do Not Boost Satisfaction

Postoperative follow-up telephone calls to patients after Mohs micrographic surgery (MMS) do not improve patient satisfaction.

Algorithm Aids Diagnosis of Atypical Melanocytic Skin Lesions

Colby Stong

The influence of body location on the intuitive diagnosis performed in teledermoscopy by dermatologists of differing skill levels was investigated.

High Frequency Basal Cell Carcinoma—Who is at Risk?

Rose Reeb

A study sought to establish prevalence of HF-BCC in the US and the characterization of patients with HF-BCC in the US.

FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use

Brian Park, PharmD

Hydrochlorothiazide is indicated for the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives.